Zura Bio Limited Stock Performance
| ZURA Stock | 6.08 0.13 2.09% |
On a scale of 0 to 100, Zura Bio holds a performance score of 11. The firm maintains a market beta of 0.79, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Zura Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Zura Bio is expected to be smaller as well. Please check Zura Bio's skewness, and the relationship between the potential upside and rate of daily change , to make a quick decision on whether Zura Bio's historical returns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Zura Bio Limited are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Zura Bio sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 99.8 M | |
| Total Cashflows From Investing Activities | -5.1 M |
Zura Bio Relative Risk vs. Return Landscape
If you would invest 399.00 in Zura Bio Limited on November 15, 2025 and sell it today you would earn a total of 209.00 from holding Zura Bio Limited or generate 52.38% return on investment over 90 days. Zura Bio Limited is currently generating 0.8495% in daily expected returns and assumes 5.7673% risk (volatility on return distribution) over the 90 days horizon. In different words, 51% of stocks are less volatile than Zura, and 83% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Zura Bio Target Price Odds to finish over Current Price
The tendency of Zura Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 6.08 | 90 days | 6.08 | about 11.23 |
Based on a normal probability distribution, the odds of Zura Bio to move above the current price in 90 days from now is about 11.23 (This Zura Bio Limited probability density function shows the probability of Zura Stock to fall within a particular range of prices over 90 days) .
Zura Bio Price Density |
| Price |
Predictive Modules for Zura Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Zura Bio Limited. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Zura Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Zura Bio is not an exception. The market had few large corrections towards the Zura Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Zura Bio Limited, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Zura Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.79 | |
β | Beta against Dow Jones | 0.79 | |
σ | Overall volatility | 0.98 | |
Ir | Information ratio | 0.14 |
Zura Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Zura Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Zura Bio Limited can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Zura Bio Limited is way too risky over 90 days horizon | |
| Zura Bio Limited appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (52.4 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Zura Bio generates negative cash flow from operations | |
| Zura Bio Limited has a frail financial position based on the latest SEC disclosures | |
| About 68.0% of the company outstanding shares are owned by institutional investors |
Zura Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Zura Stock often depends not only on the future outlook of the current and potential Zura Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Zura Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 75.1 M | |
| Cash And Short Term Investments | 176.5 M |
Zura Bio Fundamentals Growth
Zura Stock prices reflect investors' perceptions of the future prospects and financial health of Zura Bio, and Zura Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Zura Stock performance.
| Return On Equity | -0.45 | ||||
| Return On Asset | -0.27 | ||||
| Current Valuation | 268.03 M | ||||
| Shares Outstanding | 65.02 M | ||||
| Price To Book | 3.86 X | ||||
| EBITDA | (55.18 M) | ||||
| Total Debt | 19.51 M | ||||
| Book Value Per Share | 1.67 X | ||||
| Cash Flow From Operations | (28.08 M) | ||||
| Earnings Per Share | (0.65) X | ||||
| Total Asset | 179.53 M | ||||
| Retained Earnings | (155.9 M) | ||||
About Zura Bio Performance
By analyzing Zura Bio's fundamental ratios, stakeholders can gain valuable insights into Zura Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Zura Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Zura Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Zura Bio Limited performance evaluation
Checking the ongoing alerts about Zura Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Zura Bio Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Zura Bio Limited is way too risky over 90 days horizon | |
| Zura Bio Limited appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (52.4 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Zura Bio generates negative cash flow from operations | |
| Zura Bio Limited has a frail financial position based on the latest SEC disclosures | |
| About 68.0% of the company outstanding shares are owned by institutional investors |
- Analyzing Zura Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Zura Bio's stock is overvalued or undervalued compared to its peers.
- Examining Zura Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Zura Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Zura Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Zura Bio's stock. These opinions can provide insight into Zura Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Zura Stock analysis
When running Zura Bio's price analysis, check to measure Zura Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zura Bio is operating at the current time. Most of Zura Bio's value examination focuses on studying past and present price action to predict the probability of Zura Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zura Bio's price. Additionally, you may evaluate how the addition of Zura Bio to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |